Brokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) PT at $111.78

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the stock, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Robert Half Inc. (NYSE:RHI) Price Target at $67.86
Next post Antofagasta plc (LON:ANTO) Given Average Recommendation of “Hold” by Brokerages